Learning Objectives

Following the completion of this conference, attendees should be able to:

1. Treat chronic hepatitis patients with the newest interferon
   free medications

2. More clearly identify the uses of the biologic agents in
   moderately severe IBD

3. Describe the potential multi organ adverse effects of the
   fecund state

4. Identify the proper patient selection for various bariatric
   treatment options

5. Identify the symptoms and treatment for small intestinal
   bacterial overgrowth

VBMC Nurses must also submit RTA